Remdesivir and Dexamethasone for the Treatment of COVID-19
Jul 20, 2020
36:28
Episode Description
Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments.
Related Article(s):
Proudly Supported by
